103 results
Page 3 of 6
8-K
EX-99.1
fuca 2t8t48xlf
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
8-K
EX-99.1
j6owup
5 Feb 21
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
8:01am
8-K
EX-10.1
8d9u20u822ph
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-99.1
4a5g7yg yn4dbrp
10 Nov 20
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:22pm
8-K
EX-99.1
wnygksw1c7loc c3bn
10 Aug 20
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:09pm
424B5
fu4e1
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
kzjs8cipxmo4
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
c6jam0 xcn4
8 Jun 20
Regulation FD Disclosure
5:04pm
8-K
EX-99.2
i0awbkm9
8 Jun 20
Regulation FD Disclosure
5:04pm
8-K
EX-99.1
l6zn8y a06o0
12 May 20
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
dfqdz b3wz
4 Mar 20
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
4:17pm
8-K
EX-99.1
c32rcdj buosf
10 Jan 20
Regulation FD Disclosure
5:16pm
8-K
EX-99.1
lcowan5x7giic
13 Nov 19
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results
6:10am
424B5
3dnqfb5 pw5renrff7
25 Oct 19
Prospectus supplement for primary offering
12:00am